Literature DB >> 3290214

Purification and characterization of a peptidoglycan-associated lipoprotein from Haemophilus influenzae.

G W Zlotnick1, V T Sanfilippo, J A Mattler, D H Kirkley, R A Boykins, R C Seid.   

Abstract

We have purified to homogeneity a peptidoglycan-associated protein from Haemophilus influenzae. Our purification process used differential extraction of cell envelopes with nondenaturing detergents. Solubilization of this protein was accomplished by heating a peptidoglycan-enriched subcellular fraction in the presence of one of several nondenaturing detergents at 55-60 degrees C. The purified protein migrated as a single band, with a Mr approximately 15,000, following sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This protein contains covalently linked fatty acids, is rich in tyrosine, but lacks methionine and tryptophan. Amino acid analysis also revealed the presence of glycerylcysteine, which has been shown to be the site of fatty acylation in other bacterial lipoproteins. Over 87% of the primary structure has been determined by sequencing high pressure liquid chromatography purified fragments derived from several endoproteinase digests. This protein belongs to a family of proteins, known as peptidoglycan associated lipoproteins, which appear to be components of the outer membranes of most Gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290214

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  In vitro characterization of peptidoglycan-associated lipoprotein (PAL)-peptidoglycan and PAL-TolB interactions.

Authors:  E Bouveret; H Bénédetti; A Rigal; E Loret; C Lazdunski
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity.

Authors:  Eric Cascales; Alain Bernadac; Marthe Gavioli; Jean-Claude Lazzaroni; Roland Lloubes
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

3.  Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera.

Authors:  R A Deich; A Anilionis; J Fulginiti; B J Metcalf; S Quataert; T Quinn-Dey; G W Zlotnick; B A Green
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypeable and type b H. influenzae.

Authors:  B A Green; B J Metcalf; T Quinn-Dey; D H Kirkley; S A Quataert; R A Deich
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms.

Authors:  M B Nelson; R S Munson; M A Apicella; D J Sikkema; J P Molleston; T F Murphy
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

6.  Mapping of a surface-exposed, conformational epitope of the P6 protein of Haemophilus influenzae.

Authors:  J A Bogdan; M A Apicella
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 7.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

8.  Characterization of an OprL null mutant of Pseudomonas putida.

Authors:  J J Rodríguez-Herva; J L Ramos
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

9.  Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins.

Authors:  J T Belisle; M E Brandt; J D Radolf; M V Norgard
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

10.  Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model.

Authors:  B A Green; M E Vazquez; G W Zlotnick; G Quigley-Reape; J D Swarts; I Green; J L Cowell; C D Bluestone; W J Doyle
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.